Russell Investments Group
ACET icon

Russell Investments Group’s Adicet Bio ACET Stock Holding History

Russell Investments Group’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-461
Closed -$8.92K – 3685
2024
Q2 		$8.92K Buy
461
+430
+1,387% +$11.5K ﹤0.01% 3098
2024
Q1 		$1.17K Buy
+31
New +$1.28K ﹤0.01% 3121
2023
Q4 		– Sell
-44
Closed -$960 – 3200
2023
Q3 		$960 Sell
44
-3,982
-99% -$141K ﹤0.01% 3343
2023
Q2 		$157K Sell
4,026
-6,893
-63% -$608K ﹤0.01% 2518
2023
Q1 		$1.01M Buy
10,919
+4,060
+59% +$510K ﹤0.01% 1962
2022
Q4 		$981K Buy
6,859
+916
+15% +$229K ﹤0.01% 1979
2022
Q3 		$1.35M Buy
5,943
+2,755
+86% +$699K ﹤0.01% 1785
2022
Q2 		$743K Buy
+3,188
New +$700K ﹤0.01% 2092
2020
Q2 		– Sell
-2,120
Closed -$244K – 3112
2020
Q1 		$244K Buy
+2,120
New +$315K ﹤0.01% 2475

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Russell Investments Group's ACET Position: Q3 2024 in Review

Russell Investments Group sold out of Adicet Bio (ACET) in Q3 2024, closing a stake of 461 shares — an estimated $8.92K sold.

Russell Investments Group first reported a position in ACET in Q1 2020 and held it in 9 quarters. The position peaked at $1.35M in Q3 2022. 64 funds tracked by Wall St. Rank hold ACET as of Q3 2024.

  • Russell Investments Group reported no remaining Adicet Bio position as of Q3 2024 after selling out during the quarter.
  • Russell Investments Group sold 461 Adicet Bio shares in Q3 2024, an estimated $8.92K.
  • Russell Investments Group first reported a position in Adicet Bio in Q1 2020 and held it in 9 quarters.
  • Russell Investments Group's Adicet Bio position peaked at $1.35M in Q3 2022.
  • 64 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2024.

Based on Russell Investments Group's 13F filing for Q3 2024, filed 13 Nov 2024.